Product correctly added to cart.

discount label
MIK665
View 3D

Biosynth logo

MIK665

CAS: 1799631-75-6

Ref. 3D-BM170717

1mg
432.00 €
2mg
615.00 €
5mg
878.00 €
10mg
1,240.00 €
25mg
2,341.00 €
Estimated delivery in United States, on Monday 14 Apr 2025

Product Information

Name:
MIK665
Description:

MIK665 is a humanized monoclonal antibody that is used for the diagnosis of cancer. It binds to a hydroxyl group on the surface of cells, which are typically overexpressed in tumor cells. MIK665 can also induce apoptosis in primary cells, such as human immunoglobulin G (IgG) and IgM-producing B lymphocytes and T lymphocytes. The antibody has been shown to activate pro-apoptotic proteins by triggering the release of cytochrome C from mitochondria. This process leads to the activation of caspases, which are enzymes that break down protein structures within cells and lead to cell death. MIK665 has been shown to inhibit viral replication through its ability to neutralize fatty acids on the surface of viruses. Its use has also been shown to be synergistic with other drugs when used in combination with chemotherapeutic agents in metastatic colorectal cancer patients.

Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
Biosynth
Long term storage:
Notes:

Chemical properties

Purity:
Min. 95%
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:

Hazard Info

UN Number:
EQ:
Class:
H Statements:
P Statements:
Forbidden to fly:
Hazard Info:
Packing Group:
LQ:

Technical inquiry about: 3D-BM170717 MIK665

Please use instead the cart to request a quotation or an order

If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.

* Mandatory fields.
Welcome to CymitQuimica!We use cookies to enhance your visit. We do not include advertising.

Please see our Cookies Policy for more details or adjust your preferences in "Settings".